Extension without change of a currently approved collection
No
Regular
02/27/2026
Requested
Previously Approved
36 Months From Approved
04/30/2026
12,611
11,578
75,822
65,903
0
0
This information collection supports Food and Drug Administration (FDA, the agency, us or we) investigational device exemption (IDE) program. Respondents include private sector domestic and foreign medical device sponsors or applicants, including medical device manufacturers, investigators, hospitals, and other healthcare organizations.
Our estimated burden for the information collection reflects an overall increase of 9,919 hours and a corresponding increase of 1,033 responses. We attribute this adjustment to an increase in the number of submissions we received over the last few years.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
02/27/2026
Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.